Stay updated on Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial
Sign up to get notified when there's something new on the Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial page.

Latest updates to the Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial page
- Check4 days agoChange DetectedThe page shows a new revision number (v3.4.2) replacing the previous (v3.4.1). This appears to be a software maintenance update with no visible changes to the study details or functionality.SummaryDifference0.0%

- Check11 days agoChange Detected- Footer revision updated from v3.4.0 to v3.4.1; a minor maintenance change that does not affect study details.SummaryDifference0.0%

- Check18 days agoChange DetectedA 'Show glossary' option was added to the page. Revision information was updated to v3.4.0, replacing v3.3.4 and updating capitalization of related labels.SummaryDifference0.2%

- Check32 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4. No visible changes to study details or eligibility criteria.SummaryDifference0.0%

- Check53 days agoChange DetectedAdded a consolidated Locations section with state-level site listings (California, Illinois, Kansas, Massachusetts, Michigan, Missouri, New York, Texas, Wisconsin) and updated the page revision from v3.3.2 to v3.3.3. The old per-state location headings were removed.SummaryDifference1.0%

- Check82 days agoChange DetectedSite revision updated from v3.2.0 to v3.3.2 (v3.3.2 added, v3.2.0 removed). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial page.